Medical Advocates
Cytomegalovirus Infection/Disease
  Main Page

 New/Noteworthy                       Drugs 
 Pregnant Women/Neonates     Economic Data
 Pediatric CMV                          Retinal Disease
 General Reports  
 Risk Factors  
Epidemiology/Incidence
Resistance 
Diagnosis/Monitoring
Prevention 
 Systemic Infection
Transplant CMV  
Management
OI Main Page Disease Main Page Main New/Noteworthy Home Page 
Last Update:  July 23, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
July 2008
 
June 2008
 
General Reports/Reviews
       

      Journal Papers, Abstracts, and Commentaries   

 
Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease.
Britt W.
Curr Top Microbiol Immunol   2008;325:417-70
 Abstract
 
Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing.
 Dumortier J, Streblow DN, Moses AV, et al
J Virol. 2008 Apr 30.
 Abstract
 
Role of the cytomegalovirus major immediate early enhancer in acute infection and
reactivation from latency.
Stinski MF, Isomura H. 
Med Microbiol Immunol. 2007 Dec 19
Abstract
 
The history of cytomegalovirus and its diseases.
Ho M.
Med Microbiol Immunol. 2007 Dec 18
Abstract
 
Cytomegalovirus infection: a driving force in human T cell immunosenescence.
Koch S, Larbi A, Ozcelik D, et al 
Ann N Y Acad Sci. 2007 Nov;1114:23-35
 Abstract
 
High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection
with seroconversion.
Ziemann M, Krueger S, Maier AB, et al  
Transfusion. 2007 Nov;47(11):1972-83.
 Abstract
 
The immunological burden of human cytomegalovirus infection.
Khan N.
Arch Immunol Ther Exp (Warsz). 2007 Oct 1
 Abstract
 
Active CMV disease does not always correlate with viral load detection.
Ruell J, Barnes C, Mutton K, et al  
Bone Marrow Transplant. 2007 Apr 30;
 Abstract
 
Healthy Aging and Latent Infection with CMV Lead to Distinct Changes in CD8(+) and
CD4(+) T-Cell Subsets in the Elderly.
Weinberger B, Lazuardi L, Weiskirchner I, et al  
Hum Immunol. 2007 Feb;68(2):86-9
 Abstract
 
The interplay between host and viral factors in shaping the outcome of cytomegalovirus
infection.
Scalzo AA, Corbett AJ, Rawlinson WD, et al 
Immunol Cell Biol. 2006 Dec 5;
 Abstract
 
Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).
Steininger C, Puchhammer-Stockl E, Popow-Kraupp T.
J Clin Virol. 2006 May 1;
Abstract

Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection:
correlation with protection from CMV disease.
Stone SF, Price P, French MA.
J Antimicrob Chemother. 2006 Apr;57(4):585-8.
Abstract
 
CMV as a cofactor enhancing progression of AIDS.
Griffiths PD.
J Clin Virol. 2006 Jan 12;
 Abstract
 
Cytomegalovirus mononucleosis as a cause of prolonged fever and prominent weight loss
 in immunocompetent adults.
Rodriguez-Bano J, Muniain MA, Borobio MV, et al 
Clin Microbiol Infect. 2004 May;10(5):468-70.
 Abstract

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood
products.
Nichols WG, Price TH, Gooley T, et al
Blood 2003 Jan 16
 Abstract 

Cytomegalovirus infection in immunocompetent patients.
Wreghitt TG, Teare EL, Sule O, et al  .
Clin Infect Dis. 2003 Dec 15; 37(12): 1603-6.
 Abstract 

Unusual manifestations of primary cytomegalovirus infection in patients without HIV
infection and without organ transplants.
Crowley B, Dempsey J, Olujohungbe A, et al. 
J Med Virol 2002 Oct;68(2):237-40
 Abstract 

 
 
Risk Factors
       
          Journal Papers, Abstracts, and Commentaries 
 
  Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted
unrelated bone marrow: analysis of infectious complications in patients treated with T cell
depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA, Carter SL, Freifeld AG, et al.  
Biol Blood Marrow Transplant. 2007 Dec;13(12):1487-98
 Abstract 
Prevention
Transplant CMV Prophylaxis      
          Journal Papers, Abstracts, and Commentaries   
 
 
Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects.
Wloch MK, Smith LR, Boutsaboualoy S, et al
J Infect Dis. 2008 Apr 29.
 Abstract
 
  New prophylactic treatment strategy for cytomegalovirus disease.
Lake KD. 
Am J Health Syst Pharm. 2003 Dec 1; 60(23 Suppl 8): S13-6
 Abstract
 
  Formulary considerations for drugs used to prevent cytomegalovirus disease.
Pescovitz MD.  
Am J Health Syst Pharm. 2003 Dec 1; 60(23
 Abstract
Resistance
 

      Journal Papers, Abstracts, and Commentaries   

 
Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and
clinical impact.
Baldanti F, Gerna G. 
J Antimicrob Chemother. 2003 Jul 29
Abstract 

Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with c
ytomegalovirus retinitis.
Jabs DA, Martin BK, Forman MS, et al 
Am J Ophthalmol 2003 Jan;135(1):26-34
 Abstract 

 
 
 
Economic Studies
             

         Journal Papers, Abstracts, and Commentaries

  Cost advantages of oral drug therapy for managing cytomegalovirus disease.
Somerville KT.
Am J Health Syst Pharm. 2003 Dec 1;60(23 Suppl 8):S9-12.
 Abstract

OI Main Page Disease Main Page Main New/Noteworthy Home Page 

CMV Infection Main Page